AVE 33.3% 0.2¢ avecho biotechnology limited

Vovaren diclofenac Revolution - a reality, page-2

  1. 2,374 Posts.
    lightbulb Created with Sketch. 739
    Nice chook. Not exactly clinical trial stuff but you can see the difference quite easily. Hopefully Novartis is getting increased sales in Japan and India to reflect the benefits so they do take tpm to the next level. Be nice to hear an update...
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.